Dyadic International Inc. (NASDAQ: DYAI)
$1.7700
-0.0200 ( -1.12% ) 25.7K
Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
Market Data
Open
$1.7700
Previous close
$1.7900
Volume
25.7K
Market cap
$54.82M
Day range
$1.7250 - $1.8980
52 week range
$0.9257 - $2.6700
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 19 | Nov 26, 2024 |
4 | Insider transactions | 1 | Nov 25, 2024 |
10-q | Quarterly Reports | 56 | Nov 12, 2024 |
8-k | 8K-related | 16 | Nov 12, 2024 |
8-k | 8K-related | 15 | Nov 12, 2024 |
8-k | 8K-related | 15 | Oct 08, 2024 |
8-k | 8K-related | 16 | Aug 13, 2024 |
10-q | Quarterly Reports | 56 | Aug 13, 2024 |
8-k | 8K-related | 17 | Jul 02, 2024 |
8-k | 8K-related | 17 | Jul 02, 2024 |